Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Teva ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) had its target price decreased by Bank of America from $23.00 to ...

Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) have been assigned an average rating of ...

Teva's business is encountering headwinds, including declining U.S. generics revenue. Read what this biotech plans to do in ...

Kerry Logistics Network Limited ('KLN'; Stock Code 0636.HK), through its subsidiary, Kerry Pharma, and Teva Pharmaceutical Hong Kong Limited ('Teva') entered into an exclusive agreement for ...

stock in favor of a historically cheap drugmaker that's more than doubled in less than two years. TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and ...

BofA lowered the firm’s price target on Teva (TEVA) to $20 from $23 and keeps a Buy rating on the shares. The firm revised lower its FY26 and ...

Teva Pharmaceutical Industries Ltd. continues to strengthen its global market position through strategic access initiatives ...

The U.S. Food and Drug Administration (FDA) has approved SELARSDI™ (ustekinumab-aekn), a biosimilar to Stelara® (ustekinumab), for treating various conditions including plaque psoriasis ...

For the week, the Tel Aviv 35 Index rose 1.8%. The index is up 4.8% for the year to date. On the foreign exchange market, the representative shekel-US dollar exchange rate was set 0.47% higher, at ...

Analyzing Volume & Open Interest Looking at the volume and open interest is an insightful way to conduct due diligence on a stock. This data can help you track the liquidity and interest for Teva ...